Scientific Coordinator
Phynova Group Ltd, United Kingdom
Michael manages the execution of Phynova’s scientific roadmap including R&D, clinical trials and regional approvals as well as contributing to client engagement. His background includes a mix of science and professional services. He has co-authored papers on soft chemical approaches to oxidattion of complex crystal phases and nutraceutical approaches to glycemic control. He earned a Masters of Chemistry from the University of Oxford and has 5 years’ experience in leadership advisory. Previously, Michael recieved an MBA from the University of Warwick where he specialized in corporate strategy for life science companies.